HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.

AbstractBACKGROUND:
Autosomal dominant cerebellar ataxias are a clinical and genetically heterogeneous group of progressive neurodegenerative diseases, at present associated with 22 loci (spinocerebellar ataxia [SCA] 1-SCA8, SCA10-SCA19, SCA21, SCA22, fibroblast growth factor 14 [FGF14]-SCA, and dentatorubral-pallidoluysian atrophy [DRPLA]). The relevant gene has been identified in 12 cases (SCA1-3, SCA6-8, SCA10, SCA12, FGF14, and DRPLA), and in all but the recently identified SCA14, SCA17, PRKCG and FGF14 genes, the defect consists of the expansion of a short nucleotide repeat.
OBJECTIVES:
To investigate the relative prevalence of SCA1-3, SCA6-8, SCA10, SCA12, and SCA17 gene expansions in Italian families with hereditary ataxia, specifically to verify the occurrence of SCA10, SCA12, and SCA17 in Italy; and to analyze samples from probands with negative test results at the initial screening by means of the repeat expansion detection technique to identify CAG/CTG expansions in novel loci.Patients Two hundred twenty-five unrelated Italian index cases with hereditary ataxia, most (n = 183) of whom presented with a clear dominantly transmitted trait.
RESULTS:
We found that SCA1 and SCA2 gene mutations accounted for most cases (21% and 24%, respectively). We found SCA3, SCA6, SCA7, SCA8, and SCA17 to be very rare (approximately 1% each), and no case of SCA10 or SCA12 was identified. Half of the index cases (113/225) were negative for expansions in the known SCA genes. Repeat expansion detection analysis performed on 111 of these cases showed a CAG/CTG repeat expansion of at least 50 triplets in 22 (20%). Twenty-one of 22 expansions could be attributed to length variation at 2 polymorphic loci (expanded repeat domain CAG/CTG 1 [ERDA1] or CTG repeat on chromosome 18q21.1 [CTG18.1]). In 1 patient, the expansion was assigned to the DRPLA gene.
CONCLUSIONS:
The distribution of SCA1-3 and SCA6-7 gene mutations is peculiar in Italy. We found a relatively high frequency of SCA1 and SCA2 gene expansions; SCA3, SCA6, and SCA7 mutations were rare, compared with other European countries. No SCA10 or SCA12 and only a few SCA8 (2/225) and SCA17 (2/225) families were detected. In patients negative for defects in known SCA genes, repeat expansion detection data strongly suggest that, at least in our population, CAG/CTG expansions in novel genes should be considered an unlikely cause of the SCA phenotype.
AuthorsAlfredo Brusco, Cinzia Gellera, Claudia Cagnoli, Alessandro Saluto, Alessia Castucci, Chiara Michielotto, Vincenza Fetoni, Caterina Mariotti, Nicola Migone, Stefano Di Donato, Franco Taroni
JournalArchives of neurology (Arch Neurol) Vol. 61 Issue 5 Pg. 727-33 (May 2004) ISSN: 0003-9942 [Print] United States
PMID15148151 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATXN1 protein, human
  • ATXN7 protein, human
  • ATXN8OS gene product, human
  • Ataxin-1
  • Ataxin-7
  • Ataxins
  • CACNA1A protein, human
  • Calcium Channels
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Proteins
  • RNA, Long Noncoding
  • RNA, Untranslated
  • Repressor Proteins
  • ATXN3 protein, human
  • Ataxin-3
Topics
  • Adult
  • Aged
  • Ataxin-1
  • Ataxin-3
  • Ataxin-7
  • Ataxins
  • Calcium Channels (genetics)
  • DNA Mutational Analysis
  • Female
  • Humans
  • Italy
  • Male
  • Microsatellite Repeats
  • Middle Aged
  • Molecular Biology
  • Nerve Tissue Proteins (genetics)
  • Nuclear Proteins (genetics)
  • Pedigree
  • Polymerase Chain Reaction
  • Proteins (genetics)
  • RNA, Long Noncoding
  • RNA, Untranslated
  • Repressor Proteins
  • Spinocerebellar Ataxias (genetics)
  • Trinucleotide Repeat Expansion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: